Zoetis to Participate in Jefferies London Healthcare Conference
Zoetis (NYSE:ZTS) has announced its participation in the Jefferies London Healthcare Conference scheduled for Wednesday, November 20, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and engage with analysts at 3:00 p.m. GMT. The session will be accessible through a live audio webcast on the company's investor relations website, with a replay available afterward.
Zoetis (NYSE:ZTS) ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference, prevista per mercoledì 20 novembre 2024. Wetteny Joseph, Vice Presidente Esecutivo e Direttore Finanziario, rappresenterà l'azienda e interagirà con gli analisti alle 15:00 GMT. La sessione sarà accessibile tramite una trasmissione audio dal vivo sul sito web delle relazioni con gli investitori dell'azienda, con una registrazione disponibile successivamente.
Zoetis (NYSE:ZTS) ha anunciado su participación en la Jefferies London Healthcare Conference, programada para el miércoles 20 de noviembre de 2024. Wetteny Joseph, Vicepresidente Ejecutivo y Director Financiero, representará a la empresa e interactuará con los analistas a las 3:00 p.m. GMT. La sesión será accesible a través de una transmisión de audio en vivo en el sitio web de relaciones con inversores de la compañía, con una repetición disponible posteriormente.
Zoetis (NYSE:ZTS)은 2024년 11월 20일 수요일에 예정된 Jefferies London Healthcare Conference에 참여한다고 발표했습니다. Wetteny Joseph 부사장 겸 재무 담당 최고 책임자가 회사를 대표하여 GMT 3:00 p.m.에 분석가들과 소통할 것입니다. 이 세션은 회사의 투자자 관계 웹사이트를 통해 실시간 오디오 웹캐스트로 접근할 수 있으며, 이후 재생이 가능할 것입니다.
Zoetis (NYSE:ZTS) a annoncé sa participation à la Jefferies London Healthcare Conference, prévue pour le mercredi 20 novembre 2024. Wetteny Joseph, Vice-Président Exécutif et Directeur Financier, représentera la société et échangera avec les analystes à 15h00 GMT. La session sera accessible via un webinaire audio en direct sur le site des relations investisseurs de l'entreprise, avec une rediffusion disponible par la suite.
Zoetis (NYSE:ZTS) hat seine Teilnahme an der Jefferies London Healthcare Conference bekannt gegeben, die für Mittwoch, den 20. November 2024, angesetzt ist. Wetteny Joseph, Executive Vice President und Chief Financial Officer, wird das Unternehmen vertreten und um 15:00 Uhr GMT mit Analysten kommunizieren. Die Sitzung wird über einen Live-Audio-Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein, mit einer späteren Wiederholung.
- None.
- None.
Investors and other interested parties will be able to access a live audio webcast of the session by visiting http://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106823355/en/
Media:
Jennifer Albano
1- 862-399-0810 (o)
jennifer.albano@zoetis.com
Laura Panza
1-973-975-5176 (o)
laura.panza@zoetis.com
Investor:
Steve Frank
1-973-822-7141 (o)
steve.frank@zoetis.com
Nick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: Zoetis Inc.
FAQ
When is Zoetis (ZTS) presenting at the Jefferies London Healthcare Conference 2024?
Who will represent Zoetis (ZTS) at the 2024 Jefferies London Healthcare Conference?
How can investors access Zoetis (ZTS) presentation at the Jefferies Conference?